William Plovanic
Stock Analyst at Canaccord Genuity
(3.00)
# 1,287
Out of 5,163 analysts
179
Total ratings
37.27%
Success rate
1.47%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences | Maintains: Buy | $7 | $4.08 | +71.57% | 7 | Mar 9, 2026 | |
| HTFL HeartFlow | Maintains: Buy | $40 | $20.49 | +95.22% | 4 | Mar 9, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $212 → $198 | $113.00 | +75.22% | 14 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $450 → $435 | $219.84 | +97.87% | 8 | Feb 19, 2026 | |
| ATRC AtriCure | Maintains: Buy | $64 → $53 | $29.85 | +77.58% | 13 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $112 → $109 | $69.13 | +57.67% | 15 | Feb 17, 2026 | |
| DXCM DexCom | Maintains: Buy | $99 → $95 | $64.24 | +47.88% | 10 | Feb 13, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $11 → $10 | $7.53 | +32.80% | 10 | Feb 13, 2026 | |
| AORT Artivion | Maintains: Buy | $51 → $48 | $36.39 | +31.90% | 5 | Feb 13, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $21.59 | +62.11% | 7 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $147 → $148 | $123.48 | +19.86% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $89 → $87 | $81.81 | +6.34% | 30 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $18.49 | +62.25% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.60 | +69.81% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.30 | +440.54% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $84.77 | +6.17% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $93.20 | +8.37% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $8.62 | +74.01% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $336.18 | -15.52% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $12.28 | +103.58% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.68 | +614.29% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $69.95 | +0.07% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $18.84 | +154.78% | 5 | Aug 3, 2023 |
TriSalus Life Sciences
Mar 9, 2026
Maintains: Buy
Price Target: $7
Current: $4.08
Upside: +71.57%
HeartFlow
Mar 9, 2026
Maintains: Buy
Price Target: $40
Current: $20.49
Upside: +95.22%
iRhythm Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $212 → $198
Current: $113.00
Upside: +75.22%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $450 → $435
Current: $219.84
Upside: +97.87%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $64 → $53
Current: $29.85
Upside: +77.58%
Boston Scientific
Feb 17, 2026
Maintains: Buy
Price Target: $112 → $109
Current: $69.13
Upside: +57.67%
DexCom
Feb 13, 2026
Maintains: Buy
Price Target: $99 → $95
Current: $64.24
Upside: +47.88%
CVRx, Inc.
Feb 13, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $7.53
Upside: +32.80%
Artivion
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $36.39
Upside: +31.90%
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $21.59
Upside: +62.11%
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $123.48
Upside: +19.86%
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $81.81
Upside: +6.34%
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $18.49
Upside: +62.25%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.60
Upside: +69.81%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.30
Upside: +440.54%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $84.77
Upside: +6.17%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $93.20
Upside: +8.37%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $8.62
Upside: +74.01%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $336.18
Upside: -15.52%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $12.28
Upside: +103.58%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.68
Upside: +614.29%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $69.95
Upside: +0.07%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $18.84
Upside: +154.78%